nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—mammary gland—lung cancer	0.042	0.523	CbGeAlD
Gentamicin—LRP2—epithelium—lung cancer	0.0234	0.291	CbGeAlD
Gentamicin—LRP2—Retinoid metabolism and transport—SDC4—lung cancer	0.0218	0.0781	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PTHLH—lung cancer	0.0203	0.0728	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—AKR1C1—lung cancer	0.0163	0.0586	CbGpPWpGaD
Gentamicin—LRP2—lung—lung cancer	0.0149	0.185	CbGeAlD
Gentamicin—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—lung cancer	0.0148	0.0531	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—SDC4—lung cancer	0.0111	0.0399	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—AKR1C1—lung cancer	0.00833	0.0299	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—SOD2—lung cancer	0.00702	0.0252	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of steroid hormones and vitamin D—POMC—lung cancer	0.007	0.0251	CbGpPWpGaD
Gentamicin—LRP2—Retinoid metabolism and transport—APOA1—lung cancer	0.00677	0.0243	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—APOA1—lung cancer	0.00568	0.0204	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.00495	0.0178	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—PIK3CA—lung cancer	0.00458	0.0165	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—ALB—lung cancer	0.0045	0.0162	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.00375	0.0135	CbGpPWpGaD
Gentamicin—LRP2—Signaling events mediated by the Hedgehog family—AKT1—lung cancer	0.00374	0.0134	CbGpPWpGaD
Gentamicin—LRP2—Diseases associated with visual transduction—APOA1—lung cancer	0.00346	0.0124	CbGpPWpGaD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—lung cancer	0.00297	0.0106	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.00292	0.0105	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AZIN2—lung cancer	0.0022	0.00791	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—COL4A3BP—lung cancer	0.0022	0.00791	CbGpPWpGaD
Gentamicin—LRP2—Vitamin B12 Metabolism—IL6—lung cancer	0.00215	0.0077	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.00205	0.00738	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.00199	0.00714	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ATP5H—lung cancer	0.00187	0.00673	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC34A2—lung cancer	0.00178	0.00638	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.00172	0.00618	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PLBD1—lung cancer	0.00167	0.00599	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.00164	0.0059	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HSD17B10—lung cancer	0.00153	0.00548	CbGpPWpGaD
Gentamicin—LRP2—Disease—PGAM1—lung cancer	0.00151	0.00542	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CKB—lung cancer	0.00142	0.0051	CbGpPWpGaD
Gentamicin—LRP2—Disease—SDC4—lung cancer	0.00141	0.00506	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AXL—lung cancer	0.0014	0.00501	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—lung cancer	0.00135	0.00484	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CNDP2—lung cancer	0.00134	0.00479	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTM2—lung cancer	0.00134	0.00479	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTMR3—lung cancer	0.0013	0.00466	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PGAM1—lung cancer	0.00127	0.00454	CbGpPWpGaD
Gentamicin—LRP2—Disease—SKI—lung cancer	0.00124	0.00447	CbGpPWpGaD
Gentamicin—LRP2—Disease—B4GALT5—lung cancer	0.00121	0.00434	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP2A7—lung cancer	0.00121	0.00433	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SDC4—lung cancer	0.00118	0.00424	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—COL4A2—lung cancer	0.00109	0.0039	CbGpPWpGaD
Gentamicin—LRP2—Disease—PXN—lung cancer	0.00108	0.00388	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—RRM1—lung cancer	0.00108	0.00386	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTA3—lung cancer	0.00108	0.00386	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GIPR—lung cancer	0.00106	0.0038	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKR1C1—lung cancer	0.00106	0.0038	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—B4GALT5—lung cancer	0.00101	0.00363	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SDC4—lung cancer	0.000988	0.00355	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTA4—lung cancer	0.000984	0.00353	CbGpPWpGaD
Gentamicin—LRP2—Disease—NPPA—lung cancer	0.000974	0.0035	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—DUSP3—lung cancer	0.000968	0.00347	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000962	0.00345	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTA2—lung cancer	0.000959	0.00344	CbGpPWpGaD
Gentamicin—LRP2—Disease—PPIA—lung cancer	0.000951	0.00341	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RHEB—lung cancer	0.000949	0.00341	CbGpPWpGaD
Gentamicin—LRP2—Disease—ALDOA—lung cancer	0.000943	0.00339	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTA1—lung cancer	0.000925	0.00332	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ABCC3—lung cancer	0.000915	0.00328	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC34A2—lung cancer	0.000904	0.00324	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GRM8—lung cancer	0.0009	0.00323	CbGpPWpGaD
Gentamicin—LRP2—Disease—ADCY1—lung cancer	0.000891	0.0032	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKR1C1—lung cancer	0.000886	0.00318	CbGpPWpGaD
Gentamicin—LRP2—Disease—ENO2—lung cancer	0.000874	0.00314	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Paclitaxel—lung cancer	0.000872	0.00136	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—SKI—lung cancer	0.000872	0.00313	CbGpPWpGaD
Gentamicin—LRP2—Disease—PPP2R1B—lung cancer	0.000868	0.00312	CbGpPWpGaD
Gentamicin—LRP2—Disease—SMARCA4—lung cancer	0.000868	0.00312	CbGpPWpGaD
Gentamicin—Nausea—Teniposide—lung cancer	0.000867	0.00135	CcSEcCtD
Gentamicin—Hypotension—Vinorelbine—lung cancer	0.000865	0.00135	CcSEcCtD
Gentamicin—Anaemia—Irinotecan—lung cancer	0.000864	0.00135	CcSEcCtD
Gentamicin—Alopecia—Cisplatin—lung cancer	0.000862	0.00134	CcSEcCtD
Gentamicin—LRP2—Metabolism—UGT1A1—lung cancer	0.00086	0.00309	CbGpPWpGaD
Gentamicin—Urticaria—Topotecan—lung cancer	0.000859	0.00134	CcSEcCtD
Gentamicin—Body temperature increased—Topotecan—lung cancer	0.000855	0.00133	CcSEcCtD
Gentamicin—Erythema—Cisplatin—lung cancer	0.000849	0.00132	CcSEcCtD
Gentamicin—Body temperature increased—Erlotinib—lung cancer	0.000846	0.00132	CcSEcCtD
Gentamicin—Visual impairment—Paclitaxel—lung cancer	0.000844	0.00132	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000843	0.00131	CcSEcCtD
Gentamicin—Anaemia—Gemcitabine—lung cancer	0.000842	0.00131	CcSEcCtD
Gentamicin—Vertigo—Irinotecan—lung cancer	0.00084	0.00131	CcSEcCtD
Gentamicin—Weight decreased—Docetaxel—lung cancer	0.000839	0.00131	CcSEcCtD
Gentamicin—Leukopenia—Irinotecan—lung cancer	0.000837	0.00131	CcSEcCtD
Gentamicin—Paraesthesia—Vinorelbine—lung cancer	0.000831	0.0013	CcSEcCtD
Gentamicin—LRP2—Metabolism—GNG11—lung cancer	0.00083	0.00298	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.000825	0.00296	CbGpPWpGaD
Gentamicin—Hypersensitivity—Vinblastine—lung cancer	0.00082	0.00128	CcSEcCtD
Gentamicin—Tinnitus—Paclitaxel—lung cancer	0.000817	0.00127	CcSEcCtD
Gentamicin—Visual disturbance—Methotrexate—lung cancer	0.000816	0.00127	CcSEcCtD
Gentamicin—Leukopenia—Gemcitabine—lung cancer	0.000815	0.00127	CcSEcCtD
Gentamicin—Neuropathy peripheral—Docetaxel—lung cancer	0.000811	0.00126	CcSEcCtD
Gentamicin—Hypertension—Irinotecan—lung cancer	0.000807	0.00126	CcSEcCtD
Gentamicin—Stomatitis—Docetaxel—lung cancer	0.000806	0.00126	CcSEcCtD
Gentamicin—Decreased appetite—Vinorelbine—lung cancer	0.000804	0.00125	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Methotrexate—lung cancer	0.000799	0.00125	CcSEcCtD
Gentamicin—Hypersensitivity—Topotecan—lung cancer	0.000797	0.00124	CcSEcCtD
Gentamicin—LRP2—Disease—ENO1—lung cancer	0.000794	0.00285	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALDOA—lung cancer	0.00079	0.00284	CbGpPWpGaD
Gentamicin—Alopecia—Etoposide—lung cancer	0.000789	0.00123	CcSEcCtD
Gentamicin—Lethargy—Methotrexate—lung cancer	0.000789	0.00123	CcSEcCtD
Gentamicin—Hypertension—Gemcitabine—lung cancer	0.000786	0.00123	CcSEcCtD
Gentamicin—Anaemia—Cisplatin—lung cancer	0.000785	0.00122	CcSEcCtD
Gentamicin—Phlebitis—Doxorubicin—lung cancer	0.000777	0.00121	CcSEcCtD
Gentamicin—Arthralgia—Gemcitabine—lung cancer	0.000775	0.00121	CcSEcCtD
Gentamicin—Alopecia—Paclitaxel—lung cancer	0.000774	0.00121	CcSEcCtD
Gentamicin—Agranulocytosis—Docetaxel—lung cancer	0.000772	0.0012	CcSEcCtD
Gentamicin—Confusional state—Irinotecan—lung cancer	0.000769	0.0012	CcSEcCtD
Gentamicin—LRP2—Metabolism—NCOA3—lung cancer	0.000767	0.00275	CbGpPWpGaD
Gentamicin—Pruritus—Topotecan—lung cancer	0.000765	0.00119	CcSEcCtD
Gentamicin—Anaphylactic shock—Irinotecan—lung cancer	0.000763	0.00119	CcSEcCtD
Gentamicin—Erythema—Paclitaxel—lung cancer	0.000763	0.00119	CcSEcCtD
Gentamicin—Feeling abnormal—Vinorelbine—lung cancer	0.000762	0.00119	CcSEcCtD
Gentamicin—Leukopenia—Cisplatin—lung cancer	0.00076	0.00119	CcSEcCtD
Gentamicin—Pruritus—Erlotinib—lung cancer	0.000757	0.00118	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PXN—lung cancer	0.000757	0.00272	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000754	0.0027	CbGpPWpGaD
Gentamicin—Vascular purpura—Doxorubicin—lung cancer	0.000749	0.00117	CcSEcCtD
Gentamicin—Thrombocytopenia—Irinotecan—lung cancer	0.000747	0.00117	CcSEcCtD
Gentamicin—LRP2—Metabolism—ABCG2—lung cancer	0.000746	0.00268	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ADCY1—lung cancer	0.000746	0.00268	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Gemcitabine—lung cancer	0.000743	0.00116	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—OXTR—lung cancer	0.000741	0.00266	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKR1C1—lung cancer	0.000741	0.00266	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GRP—lung cancer	0.000741	0.00266	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Docetaxel—lung cancer	0.000739	0.00115	CcSEcCtD
Gentamicin—LRP2—Disease—APP—lung cancer	0.000738	0.00265	CbGpPWpGaD
Gentamicin—Dizziness—Vinblastine—lung cancer	0.000736	0.00115	CcSEcCtD
Gentamicin—Convulsion—Cisplatin—lung cancer	0.000736	0.00115	CcSEcCtD
Gentamicin—Urticaria—Vinorelbine—lung cancer	0.000735	0.00115	CcSEcCtD
Gentamicin—LRP2—Disease—FGF9—lung cancer	0.000732	0.00263	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ENO2—lung cancer	0.000732	0.00263	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HPGDS—lung cancer	0.000732	0.00263	CbGpPWpGaD
Gentamicin—Body temperature increased—Vinorelbine—lung cancer	0.000731	0.00114	CcSEcCtD
Gentamicin—Thrombocytopenia—Gemcitabine—lung cancer	0.000728	0.00114	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPP2R1B—lung cancer	0.000727	0.00261	CbGpPWpGaD
Gentamicin—Anaemia—Etoposide—lung cancer	0.000719	0.00112	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000717	0.00257	CbGpPWpGaD
Gentamicin—Visual impairment—Docetaxel—lung cancer	0.000716	0.00112	CcSEcCtD
Gentamicin—Dizziness—Topotecan—lung cancer	0.000715	0.00112	CcSEcCtD
Gentamicin—Hypotension—Irinotecan—lung cancer	0.000713	0.00111	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTT1—lung cancer	0.00071	0.00255	CbGpPWpGaD
Gentamicin—Vomiting—Vinblastine—lung cancer	0.000708	0.0011	CcSEcCtD
Gentamicin—Dizziness—Erlotinib—lung cancer	0.000708	0.0011	CcSEcCtD
Gentamicin—Anaemia—Paclitaxel—lung cancer	0.000705	0.0011	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2A6—lung cancer	0.000701	0.00252	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GCLC—lung cancer	0.000701	0.00252	CbGpPWpGaD
Gentamicin—LRP2—Disease—JUNB—lung cancer	0.000699	0.00251	CbGpPWpGaD
Gentamicin—Vertigo—Etoposide—lung cancer	0.000699	0.00109	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000699	0.00251	CbGpPWpGaD
Gentamicin—Headache—Vinblastine—lung cancer	0.000697	0.00109	CcSEcCtD
Gentamicin—Leukopenia—Etoposide—lung cancer	0.000696	0.00109	CcSEcCtD
Gentamicin—Purpura—Doxorubicin—lung cancer	0.000695	0.00108	CcSEcCtD
Gentamicin—Hypotension—Gemcitabine—lung cancer	0.000695	0.00108	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GNG11—lung cancer	0.000694	0.00249	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Cisplatin—lung cancer	0.000693	0.00108	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000692	0.00108	CcSEcCtD
Gentamicin—Vomiting—Topotecan—lung cancer	0.000688	0.00107	CcSEcCtD
Gentamicin—Paraesthesia—Irinotecan—lung cancer	0.000685	0.00107	CcSEcCtD
Gentamicin—Vertigo—Paclitaxel—lung cancer	0.000685	0.00107	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC22A18—lung cancer	0.000685	0.00246	CbGpPWpGaD
Gentamicin—Lethargy—Doxorubicin—lung cancer	0.000684	0.00107	CcSEcCtD
Gentamicin—Leukopenia—Paclitaxel—lung cancer	0.000683	0.00106	CcSEcCtD
Gentamicin—Rash—Topotecan—lung cancer	0.000682	0.00106	CcSEcCtD
Gentamicin—Hypersensitivity—Vinorelbine—lung cancer	0.000682	0.00106	CcSEcCtD
Gentamicin—Dermatitis—Topotecan—lung cancer	0.000681	0.00106	CcSEcCtD
Gentamicin—Vomiting—Erlotinib—lung cancer	0.00068	0.00106	CcSEcCtD
Gentamicin—Thrombocytopenia—Cisplatin—lung cancer	0.000678	0.00106	CcSEcCtD
Gentamicin—Headache—Topotecan—lung cancer	0.000678	0.00106	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000677	0.00106	CcSEcCtD
Gentamicin—Rash—Erlotinib—lung cancer	0.000675	0.00105	CcSEcCtD
Gentamicin—Dermatitis—Erlotinib—lung cancer	0.000674	0.00105	CcSEcCtD
Gentamicin—Convulsion—Etoposide—lung cancer	0.000674	0.00105	CcSEcCtD
Gentamicin—Hypertension—Etoposide—lung cancer	0.000671	0.00105	CcSEcCtD
Gentamicin—Headache—Erlotinib—lung cancer	0.00067	0.00105	CcSEcCtD
Gentamicin—Paraesthesia—Gemcitabine—lung cancer	0.000667	0.00104	CcSEcCtD
Gentamicin—LRP2—Metabolism—ENO1—lung cancer	0.000665	0.00239	CbGpPWpGaD
Gentamicin—Decreased appetite—Irinotecan—lung cancer	0.000663	0.00103	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000662	0.00238	CbGpPWpGaD
Gentamicin—Eosinophilia—Methotrexate—lung cancer	0.000662	0.00103	CcSEcCtD
Gentamicin—Nausea—Vinblastine—lung cancer	0.000661	0.00103	CcSEcCtD
Gentamicin—Convulsion—Paclitaxel—lung cancer	0.000661	0.00103	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—VEGFC—lung cancer	0.00066	0.00237	CbGpPWpGaD
Gentamicin—Hypertension—Paclitaxel—lung cancer	0.000658	0.00103	CcSEcCtD
Gentamicin—Alopecia—Docetaxel—lung cancer	0.000656	0.00102	CcSEcCtD
Gentamicin—Pruritus—Vinorelbine—lung cancer	0.000655	0.00102	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.000654	0.00235	CbGpPWpGaD
Gentamicin—Arthralgia—Paclitaxel—lung cancer	0.000649	0.00101	CcSEcCtD
Gentamicin—Hypotension—Cisplatin—lung cancer	0.000647	0.00101	CcSEcCtD
Gentamicin—Erythema—Docetaxel—lung cancer	0.000646	0.00101	CcSEcCtD
Gentamicin—Decreased appetite—Gemcitabine—lung cancer	0.000646	0.00101	CcSEcCtD
Gentamicin—Nausea—Topotecan—lung cancer	0.000642	0.001	CcSEcCtD
Gentamicin—Confusional state—Etoposide—lung cancer	0.00064	0.000998	CcSEcCtD
Gentamicin—Nausea—Erlotinib—lung cancer	0.000636	0.000991	CcSEcCtD
Gentamicin—Anaphylactic shock—Etoposide—lung cancer	0.000635	0.00099	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000631	0.000985	CcSEcCtD
Gentamicin—Feeling abnormal—Irinotecan—lung cancer	0.000629	0.000981	CcSEcCtD
Gentamicin—Confusional state—Paclitaxel—lung cancer	0.000628	0.000979	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ADCY1—lung cancer	0.000624	0.00224	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Paclitaxel—lung cancer	0.000622	0.000971	CcSEcCtD
Gentamicin—Paraesthesia—Cisplatin—lung cancer	0.000622	0.00097	CcSEcCtD
Gentamicin—Thrombocytopenia—Etoposide—lung cancer	0.000621	0.000969	CcSEcCtD
Gentamicin—Feeling abnormal—Gemcitabine—lung cancer	0.000613	0.000955	CcSEcCtD
Gentamicin—LRP2—Disease—FOXO3—lung cancer	0.000613	0.0022	CbGpPWpGaD
Gentamicin—Dizziness—Vinorelbine—lung cancer	0.000612	0.000954	CcSEcCtD
Gentamicin—Hypokalaemia—Doxorubicin—lung cancer	0.00061	0.000951	CcSEcCtD
Gentamicin—Thrombocytopenia—Paclitaxel—lung cancer	0.000609	0.00095	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PPP2R1B—lung cancer	0.000608	0.00218	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SMARCA4—lung cancer	0.000608	0.00218	CbGpPWpGaD
Gentamicin—Body temperature increased—Irinotecan—lung cancer	0.000603	0.000941	CcSEcCtD
Gentamicin—Decreased appetite—Cisplatin—lung cancer	0.000602	0.000939	CcSEcCtD
Gentamicin—Anaemia—Docetaxel—lung cancer	0.000597	0.000932	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2E1—lung cancer	0.000596	0.00214	CbGpPWpGaD
Gentamicin—Hypotension—Etoposide—lung cancer	0.000593	0.000925	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—lung cancer	0.000591	0.000921	CcSEcCtD
Gentamicin—LRP2—Metabolism—NQO1—lung cancer	0.00059	0.00212	CbGpPWpGaD
Gentamicin—Vomiting—Vinorelbine—lung cancer	0.000588	0.000918	CcSEcCtD
Gentamicin—Body temperature increased—Gemcitabine—lung cancer	0.000588	0.000917	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HSPB1—lung cancer	0.000586	0.0021	CbGpPWpGaD
Gentamicin—Rash—Vinorelbine—lung cancer	0.000583	0.00091	CcSEcCtD
Gentamicin—Dermatitis—Vinorelbine—lung cancer	0.000583	0.000909	CcSEcCtD
Gentamicin—Hypotension—Paclitaxel—lung cancer	0.000582	0.000907	CcSEcCtD
Gentamicin—Stomatitis—Methotrexate—lung cancer	0.000581	0.000906	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PTHLH—lung cancer	0.00058	0.00208	CbGpPWpGaD
Gentamicin—Headache—Vinorelbine—lung cancer	0.00058	0.000904	CcSEcCtD
Gentamicin—Leukopenia—Docetaxel—lung cancer	0.000579	0.000902	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	0.000577	0.00207	CbGpPWpGaD
Gentamicin—Eosinophilia—Doxorubicin—lung cancer	0.000573	0.000894	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	0.000572	0.00205	CbGpPWpGaD
Gentamicin—Feeling abnormal—Cisplatin—lung cancer	0.000571	0.000891	CcSEcCtD
Gentamicin—Paraesthesia—Etoposide—lung cancer	0.00057	0.000889	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000567	0.000884	CcSEcCtD
Gentamicin—Hypersensitivity—Irinotecan—lung cancer	0.000562	0.000877	CcSEcCtD
Gentamicin—Convulsion—Docetaxel—lung cancer	0.00056	0.000873	CcSEcCtD
Gentamicin—Paraesthesia—Paclitaxel—lung cancer	0.000559	0.000872	CcSEcCtD
Gentamicin—Hypertension—Docetaxel—lung cancer	0.000558	0.00087	CcSEcCtD
Gentamicin—Agranulocytosis—Methotrexate—lung cancer	0.000556	0.000868	CcSEcCtD
Gentamicin—Decreased appetite—Etoposide—lung cancer	0.000552	0.000861	CcSEcCtD
Gentamicin—Arthralgia—Docetaxel—lung cancer	0.00055	0.000858	CcSEcCtD
Gentamicin—Nausea—Vinorelbine—lung cancer	0.00055	0.000857	CcSEcCtD
Gentamicin—Body temperature increased—Cisplatin—lung cancer	0.000548	0.000854	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ANXA1—lung cancer	0.000545	0.00196	CbGpPWpGaD
Gentamicin—LRP2—Disease—HES1—lung cancer	0.000543	0.00195	CbGpPWpGaD
Gentamicin—Decreased appetite—Paclitaxel—lung cancer	0.000541	0.000844	CcSEcCtD
Gentamicin—Confusional state—Docetaxel—lung cancer	0.000532	0.00083	CcSEcCtD
Gentamicin—LRP2—Metabolism—STK11—lung cancer	0.000532	0.00191	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FLT1—lung cancer	0.000528	0.0019	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Docetaxel—lung cancer	0.000527	0.000823	CcSEcCtD
Gentamicin—Pruritus—Gemcitabine—lung cancer	0.000526	0.00082	CcSEcCtD
Gentamicin—Weight decreased—Doxorubicin—lung cancer	0.000524	0.000817	CcSEcCtD
Gentamicin—Feeling abnormal—Etoposide—lung cancer	0.000523	0.000816	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—NOTCH3—lung cancer	0.000517	0.00186	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APP—lung cancer	0.000517	0.00186	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Docetaxel—lung cancer	0.000516	0.000806	CcSEcCtD
Gentamicin—Visual impairment—Methotrexate—lung cancer	0.000516	0.000804	CcSEcCtD
Gentamicin—Feeling abnormal—Paclitaxel—lung cancer	0.000513	0.0008	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FGF9—lung cancer	0.000513	0.00184	CbGpPWpGaD
Gentamicin—Hypersensitivity—Cisplatin—lung cancer	0.00051	0.000796	CcSEcCtD
Gentamicin—LRP2—Disease—ERCC2—lung cancer	0.000507	0.00182	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Doxorubicin—lung cancer	0.000506	0.000789	CcSEcCtD
Gentamicin—Dizziness—Irinotecan—lung cancer	0.000505	0.000787	CcSEcCtD
Gentamicin—Urticaria—Etoposide—lung cancer	0.000504	0.000786	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—lung cancer	0.000503	0.000785	CcSEcCtD
Gentamicin—Body temperature increased—Etoposide—lung cancer	0.000502	0.000783	CcSEcCtD
Gentamicin—Tinnitus—Methotrexate—lung cancer	0.000499	0.000778	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	0.000499	0.00179	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB3—lung cancer	0.000496	0.00178	CbGpPWpGaD
Gentamicin—Urticaria—Paclitaxel—lung cancer	0.000494	0.000771	CcSEcCtD
Gentamicin—Hypotension—Docetaxel—lung cancer	0.000493	0.000769	CcSEcCtD
Gentamicin—Body temperature increased—Paclitaxel—lung cancer	0.000492	0.000767	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTP1—lung cancer	0.000492	0.00177	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JUNB—lung cancer	0.000489	0.00176	CbGpPWpGaD
Gentamicin—Vomiting—Irinotecan—lung cancer	0.000485	0.000757	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—lung cancer	0.000482	0.000751	CcSEcCtD
Gentamicin—Rash—Irinotecan—lung cancer	0.000481	0.00075	CcSEcCtD
Gentamicin—Dermatitis—Irinotecan—lung cancer	0.000481	0.00075	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000481	0.00075	CcSEcCtD
Gentamicin—LRP2—Metabolism—CAT—lung cancer	0.000479	0.00172	CbGpPWpGaD
Gentamicin—Headache—Irinotecan—lung cancer	0.000478	0.000746	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—EP300—lung cancer	0.000476	0.00171	CbGpPWpGaD
Gentamicin—LRP2—Disease—TERT—lung cancer	0.000476	0.00171	CbGpPWpGaD
Gentamicin—Paraesthesia—Docetaxel—lung cancer	0.000474	0.000739	CcSEcCtD
Gentamicin—Alopecia—Methotrexate—lung cancer	0.000473	0.000738	CcSEcCtD
Gentamicin—Vomiting—Gemcitabine—lung cancer	0.000473	0.000737	CcSEcCtD
Gentamicin—Rash—Gemcitabine—lung cancer	0.000469	0.000731	CcSEcCtD
Gentamicin—Dermatitis—Gemcitabine—lung cancer	0.000468	0.00073	CcSEcCtD
Gentamicin—Hypersensitivity—Etoposide—lung cancer	0.000468	0.000729	CcSEcCtD
Gentamicin—Erythema—Methotrexate—lung cancer	0.000466	0.000727	CcSEcCtD
Gentamicin—Headache—Gemcitabine—lung cancer	0.000466	0.000726	CcSEcCtD
Gentamicin—LRP2—Metabolism—ABCB1—lung cancer	0.000466	0.00167	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGFR1—lung cancer	0.000462	0.00166	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Doxorubicin—lung cancer	0.000461	0.000719	CcSEcCtD
Gentamicin—Decreased appetite—Docetaxel—lung cancer	0.000459	0.000715	CcSEcCtD
Gentamicin—Hypersensitivity—Paclitaxel—lung cancer	0.000459	0.000715	CcSEcCtD
Gentamicin—LRP2—Metabolism—TYMS—lung cancer	0.000457	0.00164	CbGpPWpGaD
Gentamicin—LRP2—Disease—HIF1A—lung cancer	0.000455	0.00163	CbGpPWpGaD
Gentamicin—Nausea—Irinotecan—lung cancer	0.000453	0.000707	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTM1—lung cancer	0.000452	0.00162	CbGpPWpGaD
Gentamicin—Pruritus—Etoposide—lung cancer	0.000449	0.0007	CcSEcCtD
Gentamicin—Visual impairment—Doxorubicin—lung cancer	0.000447	0.000697	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—STK11—lung cancer	0.000444	0.0016	CbGpPWpGaD
Gentamicin—Nausea—Gemcitabine—lung cancer	0.000442	0.000689	CcSEcCtD
Gentamicin—Vomiting—Cisplatin—lung cancer	0.000441	0.000687	CcSEcCtD
Gentamicin—Pruritus—Paclitaxel—lung cancer	0.00044	0.000687	CcSEcCtD
Gentamicin—LRP2—Disease—APOA1—lung cancer	0.000439	0.00158	CbGpPWpGaD
Gentamicin—Rash—Cisplatin—lung cancer	0.000437	0.000681	CcSEcCtD
Gentamicin—Dermatitis—Cisplatin—lung cancer	0.000436	0.000681	CcSEcCtD
Gentamicin—Feeling abnormal—Docetaxel—lung cancer	0.000435	0.000678	CcSEcCtD
Gentamicin—Tinnitus—Doxorubicin—lung cancer	0.000432	0.000674	CcSEcCtD
Gentamicin—Anaemia—Methotrexate—lung cancer	0.000431	0.000672	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FOXO3—lung cancer	0.000429	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP1A1—lung cancer	0.000428	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ERCC2—lung cancer	0.000425	0.00153	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—AVP—lung cancer	0.000424	0.00152	CbGpPWpGaD
Gentamicin—Dizziness—Etoposide—lung cancer	0.00042	0.000655	CcSEcCtD
Gentamicin—Vertigo—Methotrexate—lung cancer	0.000419	0.000653	CcSEcCtD
Gentamicin—Body temperature increased—Docetaxel—lung cancer	0.000417	0.00065	CcSEcCtD
Gentamicin—Leukopenia—Methotrexate—lung cancer	0.000417	0.00065	CcSEcCtD
Gentamicin—Dizziness—Paclitaxel—lung cancer	0.000412	0.000642	CcSEcCtD
Gentamicin—Nausea—Cisplatin—lung cancer	0.000412	0.000642	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCC3—lung cancer	0.00041	0.00147	CbGpPWpGaD
Gentamicin—Alopecia—Doxorubicin—lung cancer	0.000409	0.000639	CcSEcCtD
Gentamicin—Convulsion—Methotrexate—lung cancer	0.000404	0.00063	CcSEcCtD
Gentamicin—Vomiting—Etoposide—lung cancer	0.000404	0.000629	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—lung cancer	0.000403	0.000629	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—AVP—lung cancer	0.000402	0.00144	CbGpPWpGaD
Gentamicin—LRP2—Disease—KIT—lung cancer	0.000401	0.00144	CbGpPWpGaD
Gentamicin—LRP2—Disease—APC—lung cancer	0.000401	0.00144	CbGpPWpGaD
Gentamicin—Rash—Etoposide—lung cancer	0.0004	0.000624	CcSEcCtD
Gentamicin—Dermatitis—Etoposide—lung cancer	0.0004	0.000624	CcSEcCtD
Gentamicin—Headache—Etoposide—lung cancer	0.000398	0.00062	CcSEcCtD
Gentamicin—Arthralgia—Methotrexate—lung cancer	0.000397	0.000619	CcSEcCtD
Gentamicin—LRP2—Disease—EGF—lung cancer	0.000396	0.00142	CbGpPWpGaD
Gentamicin—Vomiting—Paclitaxel—lung cancer	0.000396	0.000617	CcSEcCtD
Gentamicin—Rash—Paclitaxel—lung cancer	0.000392	0.000612	CcSEcCtD
Gentamicin—Dermatitis—Paclitaxel—lung cancer	0.000392	0.000611	CcSEcCtD
Gentamicin—Headache—Paclitaxel—lung cancer	0.00039	0.000608	CcSEcCtD
Gentamicin—Hypersensitivity—Docetaxel—lung cancer	0.000389	0.000606	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—IGF1R—lung cancer	0.000387	0.00139	CbGpPWpGaD
Gentamicin—Confusional state—Methotrexate—lung cancer	0.000383	0.000598	CcSEcCtD
Gentamicin—Anaphylactic shock—Methotrexate—lung cancer	0.00038	0.000593	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HES1—lung cancer	0.00038	0.00136	CbGpPWpGaD
Gentamicin—Nausea—Etoposide—lung cancer	0.000377	0.000588	CcSEcCtD
Gentamicin—LRP2—Disease—BRAF—lung cancer	0.000377	0.00135	CbGpPWpGaD
Gentamicin—Pruritus—Docetaxel—lung cancer	0.000373	0.000582	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—lung cancer	0.000373	0.000582	CcSEcCtD
Gentamicin—Thrombocytopenia—Methotrexate—lung cancer	0.000372	0.000581	CcSEcCtD
Gentamicin—LRP2—Disease—IL6R—lung cancer	0.000372	0.00134	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—GNG11—lung cancer	0.000372	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Disease—CREBBP—lung cancer	0.000372	0.00133	CbGpPWpGaD
Gentamicin—Nausea—Paclitaxel—lung cancer	0.00037	0.000577	CcSEcCtD
Gentamicin—LRP2—Metabolism—APOA1—lung cancer	0.000368	0.00132	CbGpPWpGaD
Gentamicin—Vertigo—Doxorubicin—lung cancer	0.000362	0.000565	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—lung cancer	0.000361	0.000563	CcSEcCtD
Gentamicin—Hypotension—Methotrexate—lung cancer	0.000355	0.000554	CcSEcCtD
Gentamicin—LRP2—Disease—MAP2K1—lung cancer	0.000355	0.00127	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CD—lung cancer	0.000352	0.00126	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	0.000352	0.00126	CbGpPWpGaD
Gentamicin—Convulsion—Doxorubicin—lung cancer	0.000349	0.000545	CcSEcCtD
Gentamicin—Dizziness—Docetaxel—lung cancer	0.000349	0.000544	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—lung cancer	0.000348	0.000543	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ERBB3—lung cancer	0.000347	0.00125	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000346	0.00054	CcSEcCtD
Gentamicin—Arthralgia—Doxorubicin—lung cancer	0.000343	0.000536	CcSEcCtD
Gentamicin—Paraesthesia—Methotrexate—lung cancer	0.000341	0.000532	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CG—lung cancer	0.000336	0.0012	CbGpPWpGaD
Gentamicin—Vomiting—Docetaxel—lung cancer	0.000335	0.000523	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ADCY1—lung cancer	0.000334	0.0012	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCG2—lung cancer	0.000334	0.0012	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—lung cancer	0.000333	0.0012	CbGpPWpGaD
Gentamicin—Rash—Docetaxel—lung cancer	0.000333	0.000519	CcSEcCtD
Gentamicin—Dermatitis—Docetaxel—lung cancer	0.000332	0.000518	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—lung cancer	0.000332	0.000518	CcSEcCtD
Gentamicin—Decreased appetite—Methotrexate—lung cancer	0.00033	0.000516	CcSEcCtD
Gentamicin—Headache—Docetaxel—lung cancer	0.00033	0.000515	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—lung cancer	0.000329	0.000513	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FGFR1—lung cancer	0.000323	0.00116	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Doxorubicin—lung cancer	0.000322	0.000503	CcSEcCtD
Gentamicin—LRP2—Metabolism—POMC—lung cancer	0.000319	0.00115	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIF1A—lung cancer	0.000319	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Disease—MDM2—lung cancer	0.000316	0.00113	CbGpPWpGaD
Gentamicin—LRP2—Disease—RAF1—lung cancer	0.000314	0.00113	CbGpPWpGaD
Gentamicin—Nausea—Docetaxel—lung cancer	0.000313	0.000489	CcSEcCtD
Gentamicin—Feeling abnormal—Methotrexate—lung cancer	0.000313	0.000489	CcSEcCtD
Gentamicin—LRP2—Metabolism—CREBBP—lung cancer	0.000311	0.00112	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB2—lung cancer	0.000311	0.00112	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TF—lung cancer	0.000311	0.00112	CbGpPWpGaD
Gentamicin—Hypotension—Doxorubicin—lung cancer	0.000308	0.00048	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—APOA1—lung cancer	0.000307	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CB—lung cancer	0.000307	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTOR—lung cancer	0.000307	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Disease—CD4—lung cancer	0.000306	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KDR—lung cancer	0.000305	0.00109	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—lung cancer	0.000304	0.00109	CbGpPWpGaD
Gentamicin—Urticaria—Methotrexate—lung cancer	0.000302	0.000471	CcSEcCtD
Gentamicin—Body temperature increased—Methotrexate—lung cancer	0.000301	0.000469	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.0003	0.000468	CcSEcCtD
Gentamicin—Paraesthesia—Doxorubicin—lung cancer	0.000296	0.000461	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CD—lung cancer	0.000295	0.00106	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALB—lung cancer	0.000291	0.00105	CbGpPWpGaD
Gentamicin—Decreased appetite—Doxorubicin—lung cancer	0.000286	0.000446	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—KIT—lung cancer	0.000281	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—lung cancer	0.000281	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APC—lung cancer	0.000281	0.00101	CbGpPWpGaD
Gentamicin—Hypersensitivity—Methotrexate—lung cancer	0.00028	0.000437	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—EGF—lung cancer	0.000277	0.000996	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—lung cancer	0.000271	0.000423	CcSEcCtD
Gentamicin—Pruritus—Methotrexate—lung cancer	0.000269	0.00042	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—POMC—lung cancer	0.000267	0.000959	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1A—lung cancer	0.000266	0.000955	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—lung cancer	0.000265	0.000952	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—BRAF—lung cancer	0.000264	0.000947	CbGpPWpGaD
Gentamicin—Urticaria—Doxorubicin—lung cancer	0.000262	0.000408	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—IL6R—lung cancer	0.000261	0.000935	CbGpPWpGaD
Gentamicin—Body temperature increased—Doxorubicin—lung cancer	0.00026	0.000406	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CREBBP—lung cancer	0.00026	0.000934	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CB—lung cancer	0.000257	0.000923	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—lung cancer	0.000257	0.000922	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—lung cancer	0.000255	0.000915	CbGpPWpGaD
Gentamicin—LRP2—Disease—EP300—lung cancer	0.000253	0.000908	CbGpPWpGaD
Gentamicin—Dizziness—Methotrexate—lung cancer	0.000251	0.000392	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MAP2K1—lung cancer	0.000248	0.000891	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—lung cancer	0.000247	0.000885	CbGpPWpGaD
Gentamicin—LRP2—Disease—SRC—lung cancer	0.000246	0.000883	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—lung cancer	0.000243	0.000378	CcSEcCtD
Gentamicin—Vomiting—Methotrexate—lung cancer	0.000242	0.000377	CcSEcCtD
Gentamicin—Rash—Methotrexate—lung cancer	0.00024	0.000374	CcSEcCtD
Gentamicin—Dermatitis—Methotrexate—lung cancer	0.000239	0.000374	CcSEcCtD
Gentamicin—Headache—Methotrexate—lung cancer	0.000238	0.000372	CcSEcCtD
Gentamicin—LRP2—Disease—STAT3—lung cancer	0.000237	0.000852	CbGpPWpGaD
Gentamicin—LRP2—Disease—NRAS—lung cancer	0.000237	0.00085	CbGpPWpGaD
Gentamicin—Pruritus—Doxorubicin—lung cancer	0.000233	0.000363	CcSEcCtD
Gentamicin—LRP2—Disease—MAPK3—lung cancer	0.000227	0.000814	CbGpPWpGaD
Gentamicin—Nausea—Methotrexate—lung cancer	0.000226	0.000352	CcSEcCtD
Gentamicin—LRP2—Metabolism—PTEN—lung cancer	0.000222	0.000798	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MDM2—lung cancer	0.000221	0.000793	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—lung cancer	0.00022	0.000791	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RAF1—lung cancer	0.00022	0.00079	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—lung cancer	0.000218	0.000782	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—lung cancer	0.000218	0.00034	CcSEcCtD
Gentamicin—LRP2—Disease—EGFR—lung cancer	0.000216	0.000774	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—AVP—lung cancer	0.000215	0.000773	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MTOR—lung cancer	0.000215	0.000772	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—lung cancer	0.000215	0.000772	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—EP300—lung cancer	0.000212	0.000761	CbGpPWpGaD
Gentamicin—Vomiting—Doxorubicin—lung cancer	0.000209	0.000326	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000209	0.000749	CbGpPWpGaD
Gentamicin—Rash—Doxorubicin—lung cancer	0.000208	0.000324	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—lung cancer	0.000207	0.000323	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CXCL8—lung cancer	0.000207	0.000742	CbGpPWpGaD
Gentamicin—Headache—Doxorubicin—lung cancer	0.000206	0.000322	CcSEcCtD
Gentamicin—LRP2—Disease—KRAS—lung cancer	0.000204	0.000731	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—lung cancer	0.000198	0.00071	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—lung cancer	0.000197	0.000709	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—lung cancer	0.000196	0.000305	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CCND1—lung cancer	0.000192	0.000691	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JUN—lung cancer	0.000192	0.000689	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—lung cancer	0.000187	0.000672	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—lung cancer	0.000187	0.000671	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1A—lung cancer	0.000186	0.000668	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—lung cancer	0.000186	0.000667	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EP300—lung cancer	0.000177	0.000636	CbGpPWpGaD
Gentamicin—LRP2—Disease—HRAS—lung cancer	0.000173	0.000622	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SRC—lung cancer	0.000172	0.000618	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—lung cancer	0.000168	0.000602	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—lung cancer	0.000166	0.000596	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NRAS—lung cancer	0.000166	0.000595	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—lung cancer	0.000166	0.000595	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—APOA1—lung cancer	0.000165	0.000591	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAPK3—lung cancer	0.000159	0.00057	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—lung cancer	0.000157	0.000563	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—lung cancer	0.000154	0.000554	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—lung cancer	0.000153	0.000549	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—lung cancer	0.000151	0.000542	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—lung cancer	0.000143	0.000512	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000139	0.000501	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—lung cancer	0.000131	0.00047	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—lung cancer	0.000131	0.000469	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—lung cancer	0.000128	0.00046	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—lung cancer	0.000127	0.000455	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HRAS—lung cancer	0.000121	0.000435	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—RAF1—lung cancer	0.000118	0.000424	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—lung cancer	0.000116	0.000417	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—lung cancer	0.000107	0.000384	CbGpPWpGaD
